Jennifer H. Foster, MD, MPH

Specialty:

Cancer and Blood Disorders

Director, Developmental Therapeutics Program

Clinical Director, Neuroblastoma Program

Associate Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine

Email: jhfoster@bcm.edu

Phone: 832-822-4242 Clinic

Languages: English

Departments:

Developmental Therapeutics Phase I Clinic
Liver Tumor Program
Neuroblastoma Program
Soft Tissue Sarcoma Program
Solid Tumor Programs
Texas Children's Cancer and Hematology Center

Office location:

Texas Children's Hospital Wallace Tower

Texas Medical Center
6701 Fannin Street
Houston, TX 77030

Get to know Jennifer H. Foster, MD, MPH

About

Dr. Jennifer Foster is a pediatric oncologist at Baylor College of Medicine/Texas Children’s Cancer and Hematology Center with clinical and research expertise in pediatric solid tumors and clinical pharmacology. She serves as Director of the Developmental Therapeutics Program and Clinical Director of the Neuroblastoma Program at Texas Children’s Cancer Center, one of the largest pediatric cancer centers in the United States.

Her clinical and research interests are to bring novel therapies into early phase clinical trials for patients with neuroblastoma and other solid tumors, as well as to mitigate toxicities of therapy. As such, she is dual board certified in Pediatric Hematology-Oncology and Clinical Pharmacology. She has expertise in moving novel agents from the pre-clinical arena to the implementation of early phase clinical trials. She successfully completed the pre-clinical evaluation for the first-in-class NEDD8 activating enzyme inhibitor pevonedistat and partnered with Takeda to develop and conduct the Phase 1 clinical trial through the Children’s Oncology Group (COG).

As the site Principal Investigator for the National Cancer Institute’s Pediatric Early Phase Clinical Trials Network, she is responsible for the implementation and conduct of these trials at our institution, and is actively investigating novel agents through our Developmental Therapeutics pre-clinical program with the goal of incorporating them into future clinical trials.

Education

School	Education	Degree	Year
Baylor College of Medicine	Fellowship	Clinical Fellow, Pharmacology	2015
Baylor College of Medicine	Fellowship	Pediatric Hematology/Oncology	2013
University of Washington School of Medicine	Residency	Pediatrics	2010
University of Washington School of Medicine	Internship	Pediatrics	2009
University of Hawaii School of Medicine	Medical School	Doctor of Medicine	2007
San Diego State University	Masters	Masters in Public Health	2003
University of Notre Dame	Bachelors	Bachelor of Arts, Mandarin Chinese	2001

Organizations

Organization Name	Role
American Academy of Pediatrics (AAP)	Member
American Medical Association (AMA)	Member
American Society of Clinical Oncology (ASCO)	Member and Mentor for the ASCO Robert A. Winn Clinical Investigator Leadership Award (CILA)
American Society of Pediatric Hematology/Oncology (ASPHO)	Member

Board Certifications

American Board of Pediatrics - Pediatrics

American Board of Pediatrics - Pediatric Hematology-Oncology

Honors and awards

2022: Dr. Peter Adamson Young Investigator Award, Children's Oncology Group (COG)
2020: Research Mentor Award, Texas Children's Hospital
2019: Faculty Award for Excellence in Patient Care, Baylor College of Medicine
2017: Awardee Rising Star in Translational Cancer Research, Society for Translational Oncology
2013: Alex’s Lemonade Stand Foundation, Research Scholar

* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.